Dinesh Patel
Chief Executive Officer en PROTAGONIST THERAPEUTICS, INC. .
Fortuna: 16 M $ al 31/03/2024
Cargos activos de Dinesh Patel
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PROTAGONIST THERAPEUTICS, INC. | Chief Executive Officer | 01/12/2008 | - |
Director/Board Member | 01/12/2008 | - | |
President | 01/12/2008 | - | |
Comptroller/Controller/Auditor | 20/03/2019 | 28/05/2019 | |
Director of Finance/CFO | 11/01/2019 | 28/05/2019 | |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | 01/12/2008 | - |
Chief Executive Officer | 06/07/2009 | - | |
President | 06/07/2009 | - |
Historial de carrera de Dinesh Patel
Antiguos cargos conocidos de Dinesh Patel.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Arête Therapeutics, Inc.
Arête Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Arête Therapeutics, Inc. develops and commercializes molecule drugs to treat cardiovascular and inflammatory diseases. It focuses on developing AR9281, an orally-administered compound that inhibits s-EH (soluble epoxide hydrolase), an enzyme that plays a key role in the metabolism of arachidonic acid. It also focuses on testing various back-up candidates as additional first-in-class anti-hypertensive plus agents. The company was founded in 2003 and is headquartered in Hayward, CA. | Chief Executive Officer | 01/01/2006 | 01/01/2008 |
President | 01/01/2006 | 01/01/2008 | |
Miikana Therapeutics, Inc.
Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | Chief Executive Officer | 01/01/2003 | 01/01/2005 |
Founder | 01/01/2003 | 01/01/2005 | |
President | 01/01/2003 | 01/01/2005 | |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01/01/1996 | 01/01/2003 |
AFFYMAX, INC. | Corporate Officer/Principal | 01/01/1993 | 01/01/1996 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1985 | 01/01/1993 |
Formación de Dinesh Patel.
Rutgers State University of New Jersey | Doctorate Degree |
Sardar Patel University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Australia | 2 |
India | 2 |
Operativa
Chief Executive Officer | 4 |
President | 4 |
Corporate Officer/Principal | 3 |
Sectorial
Health Technology | 8 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AFFYMAX, INC. | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
Miikana Therapeutics, Inc.
Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | Health Technology |
Arête Therapeutics, Inc.
Arête Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Arête Therapeutics, Inc. develops and commercializes molecule drugs to treat cardiovascular and inflammatory diseases. It focuses on developing AR9281, an orally-administered compound that inhibits s-EH (soluble epoxide hydrolase), an enzyme that plays a key role in the metabolism of arachidonic acid. It also focuses on testing various back-up candidates as additional first-in-class anti-hypertensive plus agents. The company was founded in 2003 and is headquartered in Hayward, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Dinesh Patel
- Experiencia